- Preview Available
- Scholarly Journal
Zelnorm, an agonist of 5-Hydroxytryptamine 4-receptor, acts as a potential antitumor drug by targeting JAK/STAT3 signaling
Zhang, Lei; Song Qiaoling; Zhang, Xinxin; Li, Li; Xu, Ximing
; et al.
Investigational New Drugs; New York Vol. 38, Iss. 2, (Apr 2020): 311-320.
DOI:10.1007/s10637-019-00790-8
This is a limited preview of the full PDF
Try and log in through your library or institution to see if they have access.